Request Appointment
1500 Duarte RdDuarte, CA 91010
Overview of Dr. Zain
Dr. Jasmine Zain is an oncologist in Duarte, CA and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Fatima Jinnah Medical College and has been in practice 30 years. Dr. Zain accepts several types of health insurance, listed below. She is one of 504 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She has more than 100 publications and over 500 citings.
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1996 - 1999- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1997
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1994 - 1995
Zucker School of Medicine at Hofstra/Northwell at Forest Hills HospitalResidency, Internal Medicine, 1989 - 1992
Fatima Jinnah Medical CollegeClass of 1987
Certifications & Licensure
FL State Medical License 2025 - Present
NJ State Medical License 2024 - 2027
CA State Medical License 2002 - 2025
NY State Medical License 1994 - 2025
CT State Medical License 2001 - 2003
NC State Medical License 1992 - 2001
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2011 May 01
- Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL) Start of enrollment: 2013 May 01
- Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas Start of enrollment: 2019 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome.Amrita Goyal, Daniel O'Leary, Bouthaina Dabaja, Wen-Kai Weng, Jasmine Zain
Journal of the American Academy of Dermatology. 2025-08-01 - Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter's transformation or transformed non-Hodgkin lymphoma: results from a phase I...Geoffrey Shouse, Canping Chen, Alexandra Muir, Leslie Popplewell, Tanya Siddiqi
Haematologica. 2025-07-03 - SOHO State of the Art Updates and Next Questions | Update on Tailoring Therapy in T Cell Lymphomas.Christina Moe, Jasmine Zain
Clinical Lymphoma, Myeloma & Leukemia. 2025-05-18
Abstracts/Posters
- Long Term Outcomes of Patients with Aggressive T-Cell Non-Hodgkin Lymphoma Undergoing Allogeneic Stem Cell Transplantation: Retrospective Results from a Single CenterJasmine M. Zain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Blinatumomab/Lenalidomide in Relapsed/Refractory Non-HodgkinÍs Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative AnalysisJasmine Zain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Phase 1 Results of Anti-PD-Ligand 1 (Durvalumab) & Lenalidomide in Patients with Cutaneous T Cell Lymphoma and Correlation with Programmed Death Ligand 1 Expression an...Jasmine Zain, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Preliminary Results of the Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Two Phase IIa Dose Expansion Cohorts in Relapsed/Refractory TP53 Wild-Type ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 StudiesClinically Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- 6th Annual Conference On How The Experts Treat Hematologic MalignanciesCity of Hope, Santa Monica, California - 9/18/2013
Press Mentions
City of Hope Doctors and Scientists Present Research on Novel Cancer Therapies at American Society of Hematology (ASH) Annual ConferenceDecember 10th, 2024
City of Hope Doctors Present Research on First KRAS Inhibitor and CAR T Cell Therapy at ASCOMay 29th, 2019- City of Hope Clinical and Laboratory Investigators Present New Research at the 60December 4th, 2018
Committees
- Co-Chair, CPRMC (Cancer Protocol Regulatory and Monitoring Committee), City of Hope National Medical Center 2017 - Present
- Member, CPRMC (Cancer Protocol Regulatory and Monitoring Committee), City of Hope National Medical Center 2016 - 2017
Professional Memberships
- American Society of HematologyMember
- American Society of OncologyMember
- Member
- American Society for Blood and Marrow TransplantationMember
- International Society of Cutaneous LymphomaMember
- Southwest Oncology GroupMember
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPOGreat West PPO
Health Net Oregon PPO
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
